Emergent BioSolutions, Inc. (EBS)
6.33
-0.04
(-0.63%)
USD |
NYSE |
Oct 02, 16:00
6.335
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Price : 6.33 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 6.41 | 6.41 | 6.24 | 6.33 | 614591.0 |
| Oct 01, 2026 | 6.56 | 6.56 | 6.29 | 6.37 | 811231.0 |
| Sep 30, 2026 | 6.88 | 6.88 | 6.56 | 6.60 | 760581.0 |
| Sep 29, 2026 | 6.82 | 6.995 | 6.745 | 6.92 | 745108.0 |
| Sep 28, 2026 | 6.75 | 6.95 | 6.60 | 6.86 | 682897.0 |
| Sep 25, 2026 | 6.79 | 6.845 | 6.67 | 6.79 | 631362.0 |
| Sep 24, 2026 | 6.60 | 6.870 | 6.56 | 6.77 | 914341.0 |
| Sep 23, 2026 | 6.73 | 6.86 | 6.58 | 6.67 | 1.055M |
| Sep 22, 2026 | 6.61 | 6.89 | 6.54 | 6.76 | 1.144M |
| Sep 21, 2026 | 6.80 | 6.896 | 6.48 | 6.55 | 1.513M |
| Sep 18, 2026 | 6.98 | 7.045 | 6.77 | 6.80 | 1.874M |
| Sep 17, 2026 | 6.84 | 7.05 | 6.795 | 7.02 | 1.379M |
| Sep 16, 2026 | 6.40 | 6.80 | 6.39 | 6.75 | 1.610M |
| Sep 15, 2026 | 6.36 | 6.47 | 6.23 | 6.36 | 1.023M |
| Sep 14, 2026 | 6.21 | 6.50 | 6.175 | 6.38 | 685147.0 |
| Sep 11, 2026 | 5.98 | 6.39 | 5.875 | 6.23 | 1.299M |
| Sep 10, 2026 | 5.59 | 5.99 | 5.50 | 5.87 | 2.392M |
| Sep 09, 2026 | 5.96 | 6.04 | 5.605 | 5.68 | 1.174M |
| Sep 08, 2026 | 6.15 | 6.15 | 5.96 | 6.00 | 703242.0 |
| Sep 04, 2026 | 6.26 | 6.30 | 6.14 | 6.21 | 998575.0 |
| Sep 03, 2026 | 6.56 | 6.60 | 5.97 | 6.23 | 1.098M |
| Sep 02, 2026 | 6.23 | 6.50 | 6.23 | 6.46 | 1.034M |
| Sep 01, 2026 | 6.16 | 6.285 | 5.995 | 6.22 | 972440.0 |
| Aug 31, 2026 | 5.88 | 6.115 | 5.80 | 6.10 | 1.126M |
| Aug 28, 2026 | 5.96 | 6.11 | 5.88 | 5.91 | 1.244M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exelixis, Inc. | 58.39 |
| Capricor Therapeutics, Inc. | 8.95 |
| ADMA Biologics, Inc. | 9.72 |
| Akebia Therapeutics, Inc. | 0.865 |
| Arcutis Biotherapeutics, Inc. | 25.16 |
Price Related Metrics
| PS Ratio | 0.4459 |
| Price to Book Value | 0.9512 |
| Price to Free Cash Flow | 3.998 |
| Earnings Yield | -56.14% |
| Market Cap | 324.73M |
| Operating PE Ratio | 2.508 |